SPRO
Spero Therapeutics Inc
1.20$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Spero Therapeutics Inc (SPRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.6 | -29 | -39 | -40 | -50 | -86 | -64 | -7.7 | -33 | -23 | -13 | |
| 0.0 | 0.3 | 0.4 | 0.4 | 0.8 | 0.8 | 0.6 | 0.9 | 0.4 | 0.0 | 0.0 | |
| 0.0 | 0.2 | 1.4 | 2.7 | 3.8 | 4.9 | 9.4 | 9.1 | 7.9 | 7.8 | 4.3 | |
| 0.4 | -3.0 | -1.2 | 3.4 | 3.7 | 4.6 | 12 | 16 | – | – | – | |
| 0.2 | -0.8 | 0.4 | -1.1 | 6.8 | -13 | 13 | 22 | -70 | 36 | -27 | |
| 0.2 | 0.8 | 0.0 | 2.4 | 0.3 | 0.2 | 64 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.2 | -0.8 | 0.0 | -83 | 30 | 10 | 7.7 | 34 | – | – | – | |
| – | – | 0.0 | – | – | – | 47 | 54 | – | – | – | |
| 15 | 34 | 121 | 70 | 16 | 14 | 28 | 10 | – | – | – | |
| – | – | – | – | -54 | -54 | -54 | -54 | – | – | – | |
| 15 | 34 | 116 | 70 | 16 | 131 | 84 | -30 | 0.2 | 0.0 | – | |
| 5.4 | 4.6 | 77 | -53 | -4.4 | 55 | 27 | -3.5 | -33 | -23 | -13 | |
| -9.8 | -30 | -39 | -42 | -50 | -86 | -64 | -7.7 | -33 | -23 | -13 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.